ArticlePloS one2025
Methodological approach to optimize a step-by-step deterministic linkage of SNDS data with a clinical database (FREGAT) of gastric/gastroesophageal junction adenocarcinoma in France: Pitfalls and learnings.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeSurvival rates in the European population with gastric and gastroesophageal junction (G/GEJ) adenocarcinoma remain low. Epidemiologic research is warranted to understand the population size, unmet need, and current treatment patterns of G/GEJ adenocarcinoma. The objective of this research was to develop an algorithm to link patients across the FRench EsoGAstric Tumours (FREGAT) and Système National des Données de Santé (SNDS) databases to develop a real-world dataset for G/GEJ adenocarcinoma.
methodsA step-by-step, indirect, deterministic record linkage algorithm was developed to match patient records from the FREGAT and SNDS databases. Corresponding variables in each data source were matched at an individual level. Each step in the linkage process used a given scoring criterion; the linkage process proceeded until a unique pair of patient records had equal observations across the databases, at which time patient data were considered linked. Due to the large number of potential matches, the linkage process was performed in two parts: first, matching on the stratified population using individual corresponding variables, and second, by linking without any stratification. Descriptive and inferential statistics were used to assess validity of the linkage process. This study was approved by the National Expertise Committee (Ethical and Scientific Committee for Research, Studies and Evaluations in the Field of Health; 5758940) and the French Personal Data Protection Agency (CNIL; 92 1441/DR 2022 088).
resultsOf 1617 patients included in the FREGAT database, 1385 (85.7%) were successfully linked to the SNDS database. A majority of the linked patients (1159 [83.7%] of 1385) were matched in the first part of the linkage process.
conclusionWe established an algorithm that enabled linkage of the FREGAT and SNDS databases that may be applied to capture additional data related to G/GEJ adenocarcinoma in France.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.